Positions & Policies

August 4, 2017

Social Health Protection

Despite considerable attention over many decades, striking inequalities among and within countries still exist. Several social factors that can influence health can be found in the image below. The Social…
Read More »
August 4, 2017

Orphan Drugs

An orphan medicinal product is one that is intended for the diagnosis, prevention or treatment of a condition that affects not more than 5 in 10 000 persons, according to…
Read More »
August 4, 2017

Rare Diseases

Rare diseases, including those of genetic origin, are life-threatening or chronically debilitating diseases which are of such low prevalence that special combined efforts are needed to address them. As a…
Read More »
August 4, 2017

Cross-Border Healthcare

The Directive 2011/24/EU, clarifies that EU patients seeking healthcare outside their country may do so as long as the type of treatment would have been normally provided at home. Payment…
Read More »
August 4, 2017

Clinical Trials

Why Participate in a Clinical Trial? There are many reasons why people choose to join a clinical trial. Some join a trial because the treatments they have tried for their health…
Read More »
August 4, 2017

Pharmacovigilance

It is a well known fact that little is truly known about any medicinal product prior to its entry into the market and interaction with a more diverse population than…
Read More »
August 4, 2017

Patient Safety

Every year, millions of patients suffer injuries or die because of unsafe and poor-quality health care. Many medical practices and risks associated with health care are emerging as major challenges…
Read More »
August 4, 2017

Blood Safety & Availability

Blood Availability Great variability exists regarding availability of blood and blood donation practices among countries, influenced by socioeconomical factors. In high-income countries, blood collection tends to be a well-established practice…
Read More »